Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide for Postural Control in COPD at Altitude
NCT03177811Phase 4Completed
- Sponsor
- University of Zurich
- Start
- May 2017
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of acetazolamide in acute mountain sickness (AMS) and hypoxia, sponsored by University of Zurich. Primary endpoint: Change in postural control at Day 2. Started May 2017; status: completed.
02
Drugs
acetazolamide
03
Conditions
acute mountain sickness (AMS)hypoxia
Beyond the preview
Go deeper on NCT03177811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03177811.